Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

A number of stocks jumped in the afternoon session after investor sentiment improved on renewed optimism that the US-China ...

LAGOS – In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and Adolescent Network (AfriYAN) Nigeria, supported by Organon, has ...

In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and ...

Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow ...

Medpace (MEDP) came out with quarterly earnings of $3.67 per share, beating the Zacks Consensus Estimate of $3.06 per share. This compares to earnings of $3.20 per share a year ago. These figures are ...

BofA lowered the firm’s price target on Organon (OGN) to $11 from $15 and keeps an Underperform rating on the shares. The firm, in its preview ...

Bank of America Securities analyst Jason Gerberry maintained a Sell rating on Organon (OGN – Research Report) today and set a price target of ...

Eli Lilly and Co. aired positive top-line data from the phase III trial called Achieve-1 testing orforglipron vs. placebo in adults with type 2 diabetes and inadequate glycemic control with diet and ...